Abstract:Key PointsInnate lymphoid cells (ILCs) are newly identified members of the lymphoid lineage with emerging roles in mediating immune responses and in regulating tissue homeostasis and inflammation.The existence of different ILC populations that can rapidly secrete immunoregulatory cytokines suggests that these cells may have evolved to provide immunity to infections. Indeed, it is notable that ILC subsets seem to be particularly prevalent at mucosal surfaces, which are constantly exposed to infectious agents in the external environment.The group 1 ILC lineage comprises ILCs such as natural killer (NK) cells that produce type 1 cytokines, notably interferon-γ and tumour necrosis factor. Other group 1 ILCs have been reported, mainly in vitro, and their physiological roles remain to be defined.The group 2 ILC population comprises ILC2s, which express interleukin-5 (IL-5) and IL-13 and require GATA-binding protein 3 (GATA3) and retinoic acid receptor-related orphan receptor-α (RORα) for their development. They have crucial roles in protective type 2 immunity to helminth infection. Furthermore, although T helper 2 cells are a major source of type 2 cytokines during allergic asthma, ILC2s also contribute to disease pathology.ILC3s were first defined as intestinal lymphoid cells that express the NK cell activating receptor NKp46, but otherwise bear little functional resemblance to conventional NK cells, and require RORγ for their development. They express IL-17A and IL-22.Recent studies have also implicated ILC3s in the development of inflammatory bowel disease. Studies in Rag2−/− mice demonstrated that, in the early phase of Citrobacter rodentium infection, IL-22 is produced from an innate cell source.Lymphoid tissue-inducer (LTi) cells are an ILC subset that appears to be closely related to ILC3s, but their exact relationship remains controversial. Together, LTi cells and ILC3s have been classified as group 3 ILCs.

S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense

ILC2s navigate tissue redistribution during infection using stage-specific S1P receptors

Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity

The Role of ILC3 in Intestinal Immunity

The Origin and Role of Innate Lymphoid Cells in the Lung

Functions of Group 2 Innate Lymphoid Cells in Tumor Microenvironment

Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses

Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells

ILC2-derived LIF licences progress from tissue to systemic immunity

Identification of Two Migratory Colon ILC2 Populations Differentially Expressing IL-17A and IL-5/IL-13

Innate Lymphoid Cells Are Double-Edged Swords Under The Mucosal Barrier

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

ILC2s-Trailblazers in the Host Response Against Intestinal Helminths

Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis

Innate lymphoid cells and gastrointestinal disease

Innate lymphoid cells and infectious diseases

Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells

Innate Lymphoid Cells and Inflammatory Bowel Disease

Innate lymphoid cells — how did we miss them?

Inflammation triggers ILC3 patrolling of the intestinal barrier

The role of innate lymphoid cells in inlfammatory dermatosis